1020576-91-3

Basic information

• Product Name: ethyl 2-((2-acetyl-4-bromophenyl)amino)-2-oxoacetate
• Synonyms: ethyl 2-((2-acetyl-4-bromophenyl)amino)-2-oxoacetate
• CAS NO: 1020576-91-3
• Molecular Weight: 314.136
• Mol File: 1020576-91-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 2-((2-acetyl-4-bromophenyl)amino)-2-oxoacetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-((2-acetyl-4-bromophenyl)amino)-2-oxoacetate(1020576-91-3)
• EPA Substance Registry System: ethyl 2-((2-acetyl-4-bromophenyl)amino)-2-oxoacetate(1020576-91-3)

Safety Data

• Hazardous Substances Data: 1020576-91-3(Hazardous Substances Data)

Upstream product

• 29124-56-9 1-(2-amino-5-bromophenyl)ethanone 
• 4755-77-5 Ethyl oxalyl chloride 

Downstream Products

• 1020576-84-4 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-4-methyl-2-quinazolinecarboxylic acid 
• 1020577-05-2 ethyl 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-4-methyl-2-quinazolinecarboxylate 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS FOR THE TREATMENT OF HYPERPARATHYROIDISM, CHRONIC RENAL FAILURE AND CHRONIC KIDNEY DISEASE

The invention relates to heterocyclic compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their pharmaceutical compositions for use in medicine for the treatment of diseases or disorders associated with the modulation of calcium sensing receptor modulators (CaSR), like e.g. hyperparathyroidism, chronic renal failure and chronic kidney disease and their complications.

FARNESOID X RECEPTOR AGONISTS

-